ALEXANDRIA, Va., June 12 -- United States Patent no. 12,296,025, issued on May 13, was assigned to VOYAGER THERAPEUTICS INC. (Lexington, Mass.).
"AAV capsid variants and uses thereof" was invented by Mathieu Emmanuel Nonnenmacher (Boston), Tyler Christopher Moyer (Boston), Jiangyu Li (Watertown, Mass.) and Dan Richard Laks (Cambridge, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to compositions and methods for the preparation, use, and/or formulation of adeno-associated virus capsid protein variants."
The patent was filed on June 27, 2024, under Application No. 18/757,141.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/neta...